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ARTICLE OPEN
Adaptation of a difﬁcult-to-manage asthma programme for
implementation in the Dutch context: a modiﬁed e-Delphi
Persijn J Honkoop1, Hilary Pinnock2, Regien MM Kievits-Smeets3, Peter J Sterk4, PN Richard Dekhuijzen5 and Johannes CCM in ’t Veen6
Patients with difﬁcult-to-manage asthma represent a heterogeneous subgroup of asthma patients who require extensive
assessment and tailored management. The International Primary Care Respiratory Group approach emphasises the importance of
differentiating patients with asthma that is difﬁcult to manage from those with severe disease. Local adaptation of this approach,
however, is required to ensure an appropriate strategy for implementation in the Dutch context. We used a modiﬁed three-round
e-Delphi approach to assess the opinion of all relevant stakeholders (general practitioners, pulmonologists, practice nurses,
pulmonary nurses and people with asthma). In the ﬁrst round, the participants were asked to provide potentially relevant items for
a difﬁcult-to-manage asthma programme, which resulted in 67 items. In the second round, we asked participants to rate the
relevance of speciﬁc items on a seven-point Likert scale, and 46 items were selected as relevant. In the third round, the selected
items were categorised and items were ranked within the categories according to relevance. Finally, we created the alphabet
acronym for the categories ‘the A–I of difﬁcult-to-manage asthma’ to resonate with an established Dutch ‘A–E acronym for
determining asthma control’. This should facilitate implementation of this programme within the existing structure of educational
material on asthma and chronic obstructive pulmonary disease (COPD) in primary care, with potential for improving management
of difﬁcult-to-manage asthma. Other countries could use a similar approach to create a locally adapted version of such a
programme.
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INTRODUCTION
Asthma is a common respiratory condition, accounting for serious
morbidity for patients and an important negative impact on
society and economy owing to high costs of medication,
hospitalisation and loss of productivity.1–3 Even now, 60% of the
asthmatics are poorly controlled, which is related to a signiﬁcant
reduction in quality of life.4,5
Mortality remains high despite the availability of effective
therapies.6 Recently, major preventable factors were found in 67%
of asthma deaths, and only a small portion of patients had such
severe asthma that mortality could not have been prevented.7
Therefore, it is of vital importance to differentiate between
patients with truly severe asthma (estimated as 3.6% of
people with asthma in the Netherlands) from persons with
difﬁcult-to-manage asthma (estimated as 17.4% of people with
asthma).8 Difﬁcult-to-manage asthma is asthma that either the
person affected or the clinician ﬁnds difﬁcult to manage, which
may or may not be driven by the severity of the disease.9
It requires identiﬁcation and management of treatable traits,10
predominantly beyond pharmacotherapy.11 By doing so,
the potentially life-saving but thus far very costly new types
of treatment can be reserved for the patients with truly
severe asthma.12,13 International guidelines deﬁne severe asthma
as asthma that requires treatment with high-dose inhaled
corticosteroids plus a second controller and/or systemic
corticosteroids to prevent it from becoming ‘uncontrolled’, or
that remains ‘uncontrolled’ despite this therapy, when supervised
by a specialised multidisciplinary team for at least 3 months.4,14,15
Within this deﬁnition, a systematic approach to reviewing all
potentially preventable and treatable factors before stepping up
treatment and/or deciding asthma is severe is not explicitly
speciﬁed, though guidelines do advocate reviewing preventable
factors. In addition, assessment of difﬁcult-to-manage asthma in
primary care might be hampered by a lack of knowledge about all
potentially preventable or treatable factors.
Therefore, Ryan et al.16 have developed the SIMPLES approach
to the primary care management of ‘difﬁcult-to-manage’ asthma,
adopted by the IPCRG (International Primary Care Respiratory
Group) in an international ‘Train the Trainer’ initiative.17 The
approach identiﬁes patients who are currently not controlled,
systematically addresses potentially preventable or treatable
factors and distinguishes those with difﬁcult-to-manage asthma
from those with severe asthma, enabling primary care physicians
to guide treatment with proper allocation to primary care or
hospital care management. This approach originated in the UK,
and before it can be successfully implemented in another country,
it is important to address potential barriers, such as differences in
healthcare systems and language issues.18–22 Furthermore, several
educational programmes regarding the management of asthma
already exist in primary care in the Netherlands.23 Therefore we
aimed to design a programme for difﬁcult-to-manage asthma,
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analogous to SIMPLES, which is tailored to the context in the
Netherlands.
RESULTS
Participants
Figure 1 presents a ﬂowchart of the participants of the three
rounds (see the Materials and Methods' section for a description of
the three rounds). All the ﬁrst round respondents were invited to
participate in the ﬁnal two rounds. In addition, several pulmonary
physicians, respiratory nurses and patients were added for rounds
2 and 3. Characteristics of the members of the ﬁnal two Delphi
rounds are presented in Table 1.
Items generated and ranked for clinical relevance
The ﬁrst Delphi round resulted in a list of 67 items, presented in
Table 2. A total of 46 items met the second-round inclusion
criterion of 80% of participants scoring a 5, 6 or 7 (above-average
relevance), also presented in Table 2 under the heading selected
yes/no. For the third round, we categorised the selected items in
the following categories:
● Background
● Diagnosis
● Monitoring
● Exacerbation
● Types of medication
● Use of medication
● Smoking
● Other irritants
● Lifestyle
● Education and self-management
● Patient Proﬁle
● Individual care plan
The ranking of items within each of these categories is given in
Table 3.
Developing an acronym
After analysis of the categories and the ranked items within the
categories, we decided to use the letters A–I of the alphabet,
resulting in ‘The A–I of difﬁcult to manage asthma’ (see Table 4).
Our main reasons were as follows:
● It is an easy-to-remember and clear acronym.
● In some parts in the Netherlands, a short version already exists,
which is used to determine the cause of insufﬁcient asthma
control (The A–E of asthma).24 By extending an existing
acronym, we hoped to facilitate implementation.
● All the relevant categories and items could be addressed within
the acronym.
Subgroup analyses
The results of the subgroup analyses comparing responses of
patients and professionals and between primary care and hospital
care are given in an online supplement (Supplementary Tables 5a
Figure 1. Flowchart of study participants. GP, general practitioner; PN, practice nurse.
Table 1. Baseline characteristics
Characteristic N (%)
Background
General practitioner 20 (45%)
Practice nurse 6 (14%)
Pulmonologist 8 (18%)
Respiratory nurse 4 (9%)
Asthma patient 6 (14%)
Gender % female 26 (59%)
Age
18–30 y 1 (2%)
31–40 y 8 (18%)
41–50 y 15 (34%)
51–65 y 18 (41%)
65+ y 2 (5%)
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Table 2. Overview of items selected in round 1 and the results of the Delphi procedure
Name item Percentage of
participants that
scored ⩾ 5
Mean
score
Selecteda
Diagnosis and monitoring
Explanation what is difﬁcult-to-manage asthma 98% 6.3 Yes
Identiﬁcation of patients with difﬁcult-to-manage asthma 93% 6.1 Yes
What is the difference between difﬁcult-to-manage asthma and severe asthma 90% 5.9 Yes
Further insight into the potential consequences of a diagnosis of severe asthma (such as the use of
biologicals, revalidation-therapy, high-altitude treatment.)
88% 5.7 Yes
Has asthma been diagnosed according to the current guidelines 81% 5.8 Yes
The role of comorbid diseases in asthma 76% 5.4 No
Differential diagnosis of asthma and which potential concurrent diagnoses require further
investigation/management
86% 5.6 Yes
Which other tests should/could be performed other than symptoms and spirometry, to diagnose asthma 86% 5.3 Yes
Role of blood eosinophils 62% 4.9 No
Role of NT-BNP 36% 4.1 No
Role of histamine-provocation 71% 5.1 No
Role of FeNO 45% 4.5 No
Role of pulmonary imagining 40% 4.1 No
Role of the ACQ 83% 5.6 Yes
Role of the AQLQ 48% 4.6 No
Role of the RIC-MON 10 26% 3.7 No
Role of spirometry 71% 5.3 No
Role of different phenotypes of asthma 83% 5.7 Yes
How to assess different phenotypes of asthma in a patient 86% 5.6 Yes
Identiﬁcation of patients with an increased risk of asthma exacerbations 90% 5.8 Yes
Frequency of monitoring for the individual patient 83% 5.4 Yes
Clear guidelines for referrals between primary and hospital care 86% 5.8 Yes
Determining current control 88% 5.8 Yes
Content of monitoring in the individual patient 90% 5.8 Yes
Additional use of spirometry in patients with no symptoms and persistent obstruction 79% 5.3 No
Additional use of spirometry in patients with a lot of symptoms and a normal lung function 79% 5.3 No
Role of peak ﬂow in daily monitoring 40% 4.0 No
Identiﬁcation of patients suitable for pulmonary rehabilitation 83% 5.5 Yes
Determining general goals of treatment 74% 5.1 No
Determining personal goals of treatment. 98% 6.0 Yes
Medication(-related) therapy
Denominate central role-inhaled corticosteroids 90% 5.9 Yes
Name common side-effects of different types of medication 93% 5.5 Yes
Pharmacotherapy for speciﬁc subgroups: does comorbidity determine medication choices 86% 5.4 Yes
Identiﬁcation of suitable patients for LTRA 76% 4.9 No
Role of inhalation instruction 90% 6.2 Yes
Role of device type 88% 5.8 Yes
Inventarisation of adherence 93% 6.0 Yes
Role of particle size 62% 4.9 No
Patient perceptions on beneﬁts and necessity of medication 93% 6.0 Yes
Non-pharmacological management
Follow-up of comorbidity 74% 5.0 No
An asthma action plan for every asthma patient 71% 5.1 No
An asthma action plan for every difﬁcult-to-manage asthma patient 98% 6.2 Yes
Recognition of causing agents of exacerbations 86% 5.7 Yes
Effect of smoking on asthma 90% 6.0 Yes
Role of passive smoking 86% 5.6 Yes
Other types of drugs 69% 5.1 No
Insight into aspeciﬁc irritants 95% 6.0 Yes
Insight into allergens 97% 6.0 Yes
Insight into occupational irritants 93% 5.8 Yes
Insight into hobby-related irritants 83% 5.5 Yes
Attention for physical activity 90% 5.8 Yes
Role of weight 90% 5.8 Yes
Identiﬁcation of obstacles for adherence (social, ﬁnancial, societal) 88% 5.7 Yes
Recognition of stress-inducing factors 81% 5.5 Yes
Self-management for all people with (difﬁcult to manage) asthma 95% 6.0 Yes
Identiﬁcation of patients suited to different types of self-management: paper, online, real-life 83% 5.5 Yes
Role of eHealth 64% 5.0 No
How to make patients aware of asthma worsening events/behaviour 93% 5.7 Yes
Education on asthma 86% 5.6 Yes
Insight into the patients personal environment 90% 5.5 Yes
Getting a patients’ environment involved in treatment 79% 5.3 No
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and 5b). There was no signiﬁcant difference between patients and
professionals in the number of items they prioritised (i.e., scored
⩾ 5), respectively, 82% vs. 80%, odds ratio = 0.89 (95% conﬁdence
interval: 0.68 to 1.17), though primary care professionals prioritised
signiﬁcantly fewer items than hospital specialists (respectively,
77% vs. 85%, odds ratio = 1.69, 95% conﬁdence interval: 1.34 to
2.12). Hospital care professionals assigned a higher score to a wide
variety of items, both clinical, such as role of blood eosinophils
and phenotypes, and behavioural parameters, such as adherence,
involving patients’ peers in management, attention for physical
activity and weight.
In another subgroup analysis, we compared the prioritisation of
items by primary and hospital care professionals and results are
presented in Supplementary Table 6 of the online supplement.
Views differed mostly in the headings Diagnosis and Education
and self-management.
DISCUSSION
Main ﬁndings
We devised a new educational programme for promoting
structured management of difﬁcult-to-manage asthma in Dutch
primary care. Our starting point was the SIMPLES programme,
and we built upon its foundation using a modiﬁed e-Delphi.
This resulted in a set of 46 items that we categorised using the
alphabet acronym. By working closely with the Dutch organisation
with a special interest in respiratory medicine (CAHAG), we were
able to embed our new programme ‘The A–I of difﬁcult-to-
manage asthma’ within existing structures of education, facilitat-
ing its implementation. Our systematic approach can be used by
other healthcare systems, so each country can create its own
locally adapted version of the SIMPLES difﬁcult-to-manage asthma
programme.
Interpretation of ﬁndings in relation to previously published work
Our programme is based on the UK-based SIMPLES approach by
Ryan et al.16 However, instead of a direct translation of this
acronym, we decided to use it as a source of items for the Delphi
process, alongside the opinion of several experts. The advantage
of this approach is that it incorporates views from local experts,
who know the Dutch situation and additionally it creates
commitment to the programme, as they were involved in the
design. In Supplementary Table 7 of the online supplement, we
provide a comparison between the original SIMPLES acronym and
our A–I of difﬁcult-to-manage asthma. All original elements of the
SIMPLES approach are represented in our programme. In addition,
our alphabet starts with establishing the diagnosis. ‘A’ stands for:
Is it asthma, what type of asthma and is it only asthma? A correct
diagnosis and understanding of phenotypes is a logical start to
the assessment of a difﬁcult-to-manage asthma patient, especially
in primary care where there are concerns about overdiagnosis,
which is estimated to be present in a signiﬁcant proportion of
patients registered as having asthma.25,26 Another addition is the
speciﬁc mentioning of exacerbations (E), whereas this is
incorporated as part of Monitoring in SIMPLES. Bel et al.14 provide
an overview of severe and difﬁcult-to-manage asthma, and they
advise the assessment of the following: persistently poor
compliance (addressed in 'Device'), persistent environmental
exposure to allergens or toxic substances ('Bronchial triggers'),
psychosocial factors ('General behaviour'), dysfunctional
breathing, vocal cord dysfunction and untreated or undertreated
comorbidities such as chronic rhinosinusitis, reﬂux disease
or obstructive sleep apnoea ('is it asthma, is it only asthma').
As shown, all of these are represented in our programme.
An additional advantage of following the alphabet is that it
provides an extensive personalised review of potentially treatable
factors, building up to an individual care plan (the letter I) that
incorporates all the treatable traits of a particular patient and
assigns goals to them. A similar approach with a Delphi procedure
was recently used in the CORONA study, which successfully
implemented an asthma and chronic obstructive pulmonary
disease (COPD) diagnostic programme, also involving primary
and hospital care.27
In several subgroup analyses, we assessed whether there were
differences between primary and hospital care and between
patients and professionals (presented in Supplementary Tables 5
and 6 of the online supplement). Generally they tended to agree
on which items are important, although hospital care assigned
signiﬁcantly higher scores to 14 items than primary care and there
were some differences regarding prioritisation. However, the
content of these 14 items and differences in prioritisation do not
seem to be related to a speciﬁc subject. Interestingly, patients
assigned a much lower importance to assessment of current
asthma control and to distinguishing phenotypes of asthma,
whereas they considered recognition and acceptance of personal
limitations more important. They also considered the use of a
questionnaire on asthma-related quality of life (AQLQ) and a
Dutch questionnaire on symptom severity (RIC-MON 10) more
important than professionals. However, it is important to note that
the total amount of participants for these subgroups were quite
small, especially for the patient group (n= 6), so we should be
cautious when interpreting these results. Also, in comparison to
the overall group, patients were somewhat younger (all below
50 years old) and more (83%) were female.
Strengths and limitations of this study
A strength of our study is that by using a Delphi approach we
were able to gather a wide range of ideas. By involving future
trainers and users of the programme in its creation, it engenders
commitment. Furthermore, by involving professionals from
primary and hospital care and also patients, we ensured the
opinions of all relevant people in the management of asthma
were included. We adopted a holistic approach to the manage-
ment of difﬁcult-to-manage asthma and by emphasising the
Table 2. (Continued )
Name item Percentage of
participants that
scored ⩾ 5
Mean
score
Selecteda
Knowledge about the relation between symptoms and work 88% 5.6 Yes
Necessity of an individual care plan for all patients with (difﬁcult to manage) asthma 83% 5.7 Yes
Recognition and acceptance of personal limitations 88% 5.7 Yes
Estimation of desire and potential for behavioural changes 88% 5.6 Yes
Abbreviations: ACQ, asthma control questionnaire; AQLQ, asthma quality of life questionnaire; FeNO, fractional exhaled nitric oxide; LTRA, leucotriene receptor
antagonist; NT-BNP, N-terminal brain natriuretic peptide; RIC-MON 10, Dutch questionnaire on symptom severity.
aYes if ⩾ 80% of participants scored ⩾ 5 on this item.
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importance of self-management and an individualised care plan,
we support patients to adapt and self-manage in the face of social,
physical and emotional challenges, which is proposed as the new
deﬁnition of health.28 Promoting self-management is pivotal in
promoting personalised medicine, thus optimising individual
medication prescription and all other behavioural aspects.
A key part of our study was that we ensured our ﬁnal
programme was adapted to the local situation. Each country has
a different healthcare system. In the Netherlands, asthma is
predominantly managed in primary care, mainly by practice
nurses (PNs) under the guidance of general practitioners (GPs).
Furthermore, there is signiﬁcant interest in asthma by
Table 3. Overview of results Delphi round 3
Category Name item Rank
Background Explanation what is difﬁcult-to-manage asthma 1
Identiﬁcation of patients with difﬁcult-to-manage asthma 2
What is the difference between difﬁcult-to-manage asthma and severe asthma 3
Clear guidelines for referrals between primary and hospital care 4
Further insight into the potential consequences of a diagnosis of severe asthma (such as the use of biologicals,
revalidation-therapy, high-altitude treatment.)
5
Diagnosis Has asthma been diagnosed according to the guidelines 1
Differential diagnosis of asthma and which potential concurrent diagnoses require further investigation 2
The role of comorbidity in asthma 3
How to assess different phenotypes of asthma in a patient 3
Role of the ACQ 3
Role of different phenotypes of asthma 6
Which other tests should/could be performed other than symptoms and spirometry, to diagnose asthma 7
Monitoring Content of monitoring in the individual patient 1
Determining current control 2
Frequency of monitoring for the individual patient 3
Exacerbation An asthma action plan for every difﬁcult-to-manage asthma patient 1
Identiﬁcation of patients with an increased risk 2
Deﬁnition of (severe) asthma exacerbation 3
Recognition of causing agents of exacerbations 4
Types of medication Denominate central role-inhaled corticosteroids 1
Pharmacotherapy for speciﬁc subgroups: does comorbidity determine medication choices 2
Name common side-effects different types of medication 3
Use of medication Role of inhalation instruction 1
Assessment of adherence 2
Role of device type 3
Smoking Effect of smoking on asthma 1
Role of passive smoking 2
Other irritants Insight into allergens 1
Insight into nonspeciﬁc irritants 2
Insight into occupational irritants 3
Insight into hobby-related irritants 4
Lifestyle Identiﬁcation of obstacles for adherence (social, ﬁnancial, societal) 1
Attention for physical activity 2
Role of weight 3
Identiﬁcation of patients suitable for pulmonary rehabilitation 4
Recognition of stress-inducing factors 5
Education and
self-management
Self-management for all people with (difﬁcult-to-manage) asthma 1
Patient perceptions on beneﬁts and necessity medications 2
Education on asthma 3
Identiﬁcation of patients suited to different types of self-management: paper, online, real-life 4
How to make patients aware of asthma worsening events/behaviour 5
Patient Proﬁle Insight into the patients' personal environment 1
Knowledge about the relation between symptoms and work 2
Individual care plan Necessity of an individual care plan for all patients with (difﬁcult-to-manage) asthma 1
Recognition and acceptance of personal limitations 2
Determining personal goals of treatment. 2
Estimation of desire and potential for behavioural changes 4
Abbreviation: ACQ, asthma control questionnaire.
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Table 4. The alphabet
A Asthma (Dutch: astma). Is it asthma, what type of asthma and is it only asthma?
Items:
● Has asthma been diagnosed according to the guidelines
● Explanation what is difﬁcult-to-manage asthma
● Identiﬁcation of patients with difﬁcult-to-manage asthma
● What is the difference between difﬁcult-to-manage asthma and severe asthma
● Role of different phenotypes of asthma
● Which other tests should/could be performed other than symptoms and spirometry, to diagnose asthma
● The role of comorbidity in asthma
● How to assess different phenotypes of asthma in a patient
● Differential diagnosis of asthma and which potential concurrent diagnoses require further investigation
● Further insight into the potential consequences of a diagnosis of severe asthma (such as the use of biologicals, revalidation-therapy, high-
altitude treatment..)
B Bronchial triggers (Blootstelling). Allergens and irritants causing symptoms
Items:
● Effect of smoking on asthma
● Insight into allergens
● Insight into nonspeciﬁc irritants
● Role of passive smoking
● Insight into occupational irritants
● Insight into hobby-related irritants
● Knowledge about the relation between symptoms and work
C Asthma control (Controle). How to assess and monitor asthma control
Items:
● Determining current control: ACQ, exacerbation rate, persistent obstruction
● Content of monitoring in the individual patient
● Role of the ACQ
● Frequency of monitoring for the individual patient
● Clear guidelines for referrals between primary and hospital care
● Identiﬁcation of patients suitable for pulmonary rehabilitation
D Device (Device). Which device and how to use it?
Items:
● Role of inhalation instruction
● Assessment of adherence
● Role of device type: match between patient and device
E Exacerbations (Exacerbaties). How to prevent, detect and treat exacerbations
Items:
● An asthma action plan for every difﬁcult-to-manage asthma patient
● Identiﬁcation of patients with an increased risk
● Deﬁnition of a (severe) asthma exacerbation
● Recognition of causing agents of exacerbations
F Pharmacotherapy (Farmacotherapie). Which types of medication for which individual patient
Items:
● Denominate central role-inhaled corticosteroids
● Patient perceptions on beneﬁts and necessity of medication
● Pharmacotherapy for speciﬁc subgroups: does comorbidity determine medication choices
● Common side-effects different types of medication
G General behaviour (Gedrag). How does behaviour and lifestyle inﬂuence asthma and how to modify it
Items:
● Attention for physical activity
● Role of weight
● Recognition of stress-inducing factors
H Help (Hulp). Strengthen the knowledge and determine who can aid a patient in disease management
Items:
● Identiﬁcation of obstacles for adherence (social, ﬁnancial, societal)
● Education on asthma
● Insight into the patients' personal environment
I Individualised care plan (Individueel Zorg Plan). How to create and use a self-management plan for each individual patient
Items:
● Self-management for all people with (difﬁcult-to-manage) asthma
● Necessity of an individual care plan for all patients with (difﬁcult-to-manage) asthma
● Recognition and acceptance of personal limitations
● Determining personal goals of treatment.
● Identiﬁcation of patients suited to different types of self-management: paper, online, real-life
● How to make patients aware of asthma worsening events/behaviour
● Estimation of desire and potential for behavioural changes
Abbreviation: ACQ, asthma control questionnaire.
Items in italic were deemed less relevant in round 3 of the modiﬁed Delphi procedure.
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policymakers, because asthma is seen as one of the chronic non-
communicable diseases in which management could increasingly
be shifted from hospital to primary care. The local situation might
be very different in another country, so a proper analysis of
reimbursement and other policy-related context should be an
integral part of an implementation programme in other countries.
Furthermore, this approach ensures that the correct patient is
treated in the right place, with referral to hospital care only after
adequate assessment in primary care.
In addition, by working closely with the Dutch organisation for
GPs and PNs with a special interest in asthma and COPD (CAHAG),
we ensured ownership by key stakeholders, facilitating imple-
mentation. Members of the CAHAG, specialised in developing
educational training programmes for courses will be asked to
write an educational programme based on this ‘alphabet’
approach. ‘The A–I of difﬁcult-to-manage asthma’ will be taught
regionally to GPs and PNs, by GPs and PNs with a special interest
in asthma and COPD. In addition, it will be taught as a 2 h
workshop on the ‘Adembenemend’ (‘Breath-taking’) course, which
is a 2-day course on the management of asthma and COPD in
primary care for care teams consisting of GPs and their PNs.
Our study has several limitations. First of all, we have used a
modiﬁed version of the Delphi procedure, with a cut-off of 80%
scoring 5, 6 or 7 on a seven-point Likert scale. Although this is a
frequently used cut-off, it is arbitrary and cut-offs vary widely
between different Delphi exercises.29,30 Also, using the 80% cut-off
criterium instead of looking at mean scores resulted in some items
being selected although their mean scores were lower than other
items that were not selected (see Table 2). However, this criterium
ensured that an item was deemed important by the majority of
our experts, whereas a mean score could have been signiﬁcantly
inﬂuenced by a minority feeling very strongly in favour (or against)
a speciﬁc item. In addition, we did not give a feedback for the
previous round median scores as is done in classic Delphi
processes. This was to enable categorisation of items between
rounds two and three, which meant that the prioritisation was
within the group rather than across all the items. Although this did
not permit a formal consensus to be achieved, it facilitated the
development of structured educational categories, which in turn
will facilitate implementation.
Another limitation is that we did not address why speciﬁc items
were chosen or deleted. Our focus was on difﬁcult-to-manage
asthma, neither asthma management in general nor speciﬁc
treatment for severe asthma. This may have affected participant
responses. Therefore, some low-priority scores may reﬂect a
perception that an item was not important generally in asthma
management, whereas other low-priority scores may only be
perceived as not important in the context of difﬁcult-to-manage
asthma. Finally, GPs and PNs without a special interest in asthma
were not selected for our Delphi, and the results could have been
different if we had. However, as the topic of this programme,
difﬁcult-to-manage asthma as opposed to severe asthma, is
relatively new for most GPs, we decided to only include GPs with
special expertise on the subject.
Implications for future research, policy and practice
Asthma is one of the chronic non-communicable diseases whose
management could be shifted more from hospital to primary care.
The ‘A–I of difﬁcult to manage asthma’ programme facilitates a
proper allocation of patients with more severe asthma to hospital
care, by selecting and treating the difﬁcult-to-manage aspects
earlier in primary care. Although our algorithm is not designed to
aid in the treatment of severe asthma, the algorithm still draws
attention to the different phenotypes of severe asthma by
questioning ‘The role of different phenotypes of asthma’ in
category A (Is it asthma, what type of asthma and is it only
asthma?). In addition, patients who do not reponse to the A–I
approach, might be identiﬁed as having severe asthma who
require referral to secondary care for targeted therapy. Although
several aspects of difﬁcult-to-manage asthma can be therapy
resistant and still require hospital care, implementation of the
programme has the potential to reduce the total number of
referred patients. In addition, it will allow earlier referral back to
primary care after hospital assessment. This might be of interest
not only for patients and workers in healthcare but also for
policymakers and health insurance companies. The impact on
primary care management and healthcare outcomes, however,
requires assessment in well-designed implementation studies.
Future research should encompass implementation outcomes
(such as knowledge gained and change in practice by GPs who
followed the programme), as well as patient health outcomes
(such as hospitalisations and measures of control) and a cost-
effectiveness analysis, to determine the success of implementing
our programme.
In addition, our results show that both among patients and
professionals, there is considerable emphasis on patient-speciﬁc
and behavioural issues, suggesting that these were seen as
particularly important in people with difﬁcult-to-manage asthma.
Future research and management should be designed taking into
account this particular emphasis.
Conclusions
In this study, we present the use of a modiﬁed e-Delphi to adapt a
UK-designed approach to managing difﬁcult-to-manage asthma
for implementation in the Netherlands. The ‘A–I of difﬁcult-to-
manage asthma’ programme is a robust and holistic approach to
the primary care management of difﬁcult-to-manage asthma,
based on the opinions of all relevant stakeholders. The inclusive
process engaged key people and organisations in the Netherlands
such that the programme has been adopted and will be
implemented as a routine component of training.
MATERIALS AND METHODS
Participants
We deﬁned a relevant subset of expert and stakeholder groups for a
difﬁcult-to-manage asthma approach. This included expert GPs and PNs
from the Dutch organisation for GPs with a special interest in asthma and
COPD (CAHAG). In addition, we approached expert pulmonary physicians
of the Working group Allergy and Asthma from the Dutch society of
pulmonologists (NVALT) and respiratory nurses working in hospital care
recommended by their professional society (V&VN). Finally, we approached
patients, who are members of the asthma patient forum of the Lung
Foundation Netherlands. All of these special interest groups have members
from all over the Netherlands, from different practices and hospitals.
Study design
We used a modiﬁed e-Delphi approach with three rounds31–34 to tailor the
SIMPLES approach to the Dutch situation.
Round 1. We aimed to obtain all potentially relevant items for a
programme about difﬁcult-to-manage asthma. Therefore, we performed a
literature review for potential items 4,14–16,35–37 and included items from
the SIMPLES approach. In addition, we selected GPs and PNs with a special
interest in asthma and respiratory nurses, asking them to suggest
additional items for a difﬁcult-to-manage asthma programme. Experts
were invited by an e-mail with a short explanation about the background
of the study. In addition, we presented a workshop at a national meeting
of GPs with a special interest in asthma and asked all the delegates
to provide us with a selection of important items for each of three
categories: ‘Diagnosis and Monitoring’, ‘Pharmacological therapy’ and
‘Non-pharmacological management’.
Round 2. At this stage, the pulmonary physicians, respiratory nurses and
people with asthma were added to obtain input from all relevant experts
and stakeholders and to validate and rate the ﬁndings of round 1. All the
participants were sent an e-mail with a link to a web-based questionnaire
(using Survey Monkey) and an invitation letter, explaining the background
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and relevance of the study. A reminder was sent after 3 weeks if we had
received no response. The online questionnaire included a list of all
potential items from the ﬁrst round, and the respondents were asked to
rate the clinical importance of each item on a seven-point Likert scale
(1 = completely irrelevant, 7 = highly relevant). An item was selected as
relevant if 80% or more of the participants indicated the item as of above-
average importance (i.e., a score of 5, 6 or 7). This analysis and further
exploratory analyses were performed with STATA 11.0 (StataCorp, College
Station, TX, USA).
Round 3. In this round, all the selected items from the second round
were grouped into categories, and respondents from round 2 were asked
to rank the items according to relevance within each category.
Finally, the items within each category were re-classiﬁed within an
educational approach that resonated with existing educational strategies
in the Netherlands and a new acronym was designed. The ranking allowed
for a distinction between more and less relevant items, which could be
used to prioritise items in time-limited training programmes.
Subgroup analyses
In two exploratory analyses, we assessed whether there were substantial
differences between patients and professionals (online supplement,
Supplementary Table 5a) and between primary care and hospital care
(online supplement, Supplementary Table 5b). A substantial difference
between two groups was arbitrarily deﬁned as a difference of 0.7 points or
more on the mean outcome (i.e., a difference of ⩾ 10%). Furthermore, we
assessed whether a particular group was more inclined to prioritise speciﬁc
items, by calculating odds ratios. Finally, we analysed whether the results
of the prioritisation of items would have differed when solely using the
results from primary or hospital care (online supplement, Supplementary
Table 6).
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